Peggy Taylor
Family Medicine · Saint Louis, MONPI 1922094135
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 333 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 45 manufacturers reported payments, led by AstraZeneca at 25.3% of the total. Reporting peaked in 2019 at $2,877 and has fallen 65.2% since, to $1,001 in 2025. Among family medicine clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $33.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- Novo Nordisk$799
- Lilly USA, LLC$571
- Johnson & Johnson$509
- AbbVie$487
- Pfizer$476
- plus $5K from 39 others
What the payments were for
- Food & beverage$11,06999%
- Education$661%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$1,049
- BREZTRI$805
- ZENPEP$366
- MOUNJARO$337
- NURTEC ODT$249
- XARELTO$243
- JARDIANCE$230
- WATCHMAN Access System$134
- Vascepa$128
- VOQUEZNA$125
- VRAYLAR$124
- EUCRISA$123
- ZORYVE$123
- ANORO$123
- Ozempic$122
- COLOGUARD$121
- CAPLYTA$120
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$114
- AEQUALIS PERFORM$114
- The Cologuard Plus Collection Kit$113
How this compares
$11,134 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZenpepLipase/Protease/Amylase | 16 | $32,825 |
| FarxigaDapagliflozin Propanediol | 42 | $29,682 |
| OzempicSemaglutide | 25 | $25,686 |
| EliquisApixaban | 28 | $18,445 |
| JardianceEmpagliflozin | 18 | $16,587 |
| TrulicityDulaglutide | 15 | $15,520 |
| LinzessLinaclotide | 28 | $15,199 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 369 | $11,729 |
| VascepaIcosapent Ethyl | 38 | $8,622 |
| SynjardyEmpagliflozin/Metformin Hcl | 20 | $7,182 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $5,647 |
| CreonLipase/Protease/Amylase | 11 | $5,547 |
| BelsomraSuvorexant | 11 | $4,789 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 204 | $4,602 |
| Naloxone Hcl | 50 | $3,946 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga, Symbicort | $2,818 | $35,32962 claims |
| Aimmune Therapeutics, Inc.Zenpep | $463 | $32,82516 claims |
| Novo NordiskOzempic | $799 | $25,68625 claims |
| Boehringer IngelheimJardiance, Synjardy | $444 | $23,76938 claims |
| AbbVieLinzess, Creon | $487 | $20,74639 claims |
| PfizerEliquis | $476 | $18,44528 claims |
| Lilly USA, LLCTrulicity | $571 | $15,52015 claims |
| MerckBelsomra | $411 | $4,78911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Saint Louis
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- David GlickSaint Louis$17K
- Aaron BjornSaint Louis$16K
- Paul RutledgeSaint Louis$16K
- Melissa MurraySaint Louis$15K
- Robert PozziSaint Louis$15K
- Amy MillerSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.